PHE_Scientific Provision for purchase of the TaqMan SARS-CoV-2 Mutation panel

Concepts

• sars
• laboratory reagents
• salisbury
• national coverage of the identification of sars-cov-2
• discrimination of the sars ccv
• panels
• purchase of the taqman sars-cov-2 mutation panel
• provision of purchase of taqman sars-cov-2 mutation panel
• interim contract
• month contract

Location

Description

PHE has awarded an interim contract to Life Technologies Ltd (Thermo Fisher Scientific) for the provision of purchase of TaqMan SARS-CoV-2 Mutation panel to facilitate in the identification and discrimination of the SARS CcV 2 variants VOC20DEC01, VOC20DEC02 and VOC21JAN02 . The roll out of these panels will help to increase the national coverage of the identification of SARS-CoV-2 across the country. It is a PHEwide 6 month contract with an option to extend for a further 6 months.

Award Detail

CPV Codes

• 33696500 - Laboratory reagents

Indicators

• Contract is suitable for SMEs.

Other Information

n/a Order Form Life Technology- Mutation Panels signed_Redacted.pdf